| CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
| TNXB |
P22105
|
tenascin XB
|
|
1.9E-02 |
0.572 |
0.731 |
| CCHCR1 |
Q8TD31
|
coiled-coil alpha-helical rod protein 1
|
|
1.0E-16 |
0.505 |
0.808 |
| C1orf141 |
Q5JVX7
|
chromosome 1 open reading frame 141
|
|
3.2E-03 |
0.691 |
0.385 |
| CFB |
P00751
|
complement factor B
|
|
4.7E-16 |
0.532 |
0.769 |
| PUS10 |
Q3MIT2
|
pseudouridine synthase 10
|
|
7.9E-14 |
0.736 |
0.346 |
| MSH5-SAPCD1 |
|
MSH5-SAPCD1 readthrough (NMD candidate)
|
|
|
0.760 |
0.423 |
| GSDMB |
Q8TAX9
|
gasdermin B
|
|
3.3E-07 |
0.670 |
0.500 |
| RTEL1-TNFRSF6B |
|
RTEL1-TNFRSF6B readthrough (NMD candidate)
|
|
|
0.682 |
0.385 |
| HSPA1L |
P34931
|
heat shock protein family A (Hsp70) member 1 like
|
|
1.1E-06 |
0.603 |
0.654 |
| GATD3A |
A0A0B4J2D5 P0DPI2
|
glutamine amidotransferase like class 1 domain containing 3A
|
|
3.0E-05 |
0.619 |
0.654 |
| INAVA |
Q3KP66
|
innate immunity activator
|
|
2.2E-04 |
0.743 |
0.346 |
| CARD9 |
Q9H257
|
caspase recruitment domain family member 9
|
|
8.1E-13 |
0.566 |
0.654 |
| MMP24OS |
A0A0U1RRL7
|
MMP24 opposite strand
|
|
|
1.000 |
0.038 |
| IFNG-AS1 |
|
IFNG antisense RNA 1
|
|
|
0.659 |
0.654 |
| LINC01475 |
|
long intergenic non-protein coding RNA 1475
|
|
|
0.780 |
0.077 |
| IL10 |
P22301
|
interleukin 10
|
|
5.9E-03 |
0.281 |
0.923 |
| LINC00598 |
|
long intergenic non-protein coding RNA 598
|
|
|
0.743 |
0.192 |
| BSN |
Q9UPA5
|
bassoon presynaptic cytomatrix protein
|
|
1.00 |
0.769 |
0.308 |
| CDH3 |
P22223
|
cadherin 3
|
|
2.8E-10 |
0.560 |
0.615 |
| C5orf66 |
Q9H5L9
|
chromosome 5 open reading frame 66
|
|
5.3E-04 |
0.760 |
0.154 |
| LINC01804 |
|
long intergenic non-protein coding RNA 1804
|
|
0.10 |
0.931 |
0.115 |
| LINC01620 |
|
long intergenic non-protein coding RNA 1620
|
|
0.45 |
0.805 |
0.269 |
| AMZ1 |
Q400G9
|
archaelysin family metallopeptidase 1
|
|
3.7E-23 |
0.821 |
0.154 |